HIGH-DOSE CHEMOTHERAPY WITH BVAC REGIMEN, AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND PRIMED PERIPHERAL-BLOOD STEM-CELLS YIELDS DURABLE REMISSIONS WITHOUT EXCESSIVE TOXICITY IN NON-HODGKINS-LYMPHOMA
P. Ely et al., HIGH-DOSE CHEMOTHERAPY WITH BVAC REGIMEN, AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND PRIMED PERIPHERAL-BLOOD STEM-CELLS YIELDS DURABLE REMISSIONS WITHOUT EXCESSIVE TOXICITY IN NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 3764-3764